You are here

Worldwide Insights Into the Patient Recruitment & Retention Services Market, 2019-2030 - Growing Demand for Orphan Drugs and Personalized Medicine

DUBLIN, May 7, 2019 /PRNewswire/ -- The "Patient Recruitment and Retention Services Market, 2019-2030" report has been added to's offering.

Patient Recruitment and Retention Services, 2019-2030

offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services. The study features an in-depth analysis, highlighting the capabilities of the various stakeholders in this domain.

One of the key objectives of the report was to estimate the existing market size and review the potential growth opportunities for patient recruitment service providers over the coming decade. Based on several parameters, we have provided an informed estimate of the likely evolution of this market in the short to mid-term and long term, for the period 2019-2030.

In addition, we have segmented the future opportunity across:

  • [A] therapeutic area (oncology, infectious diseases, cardiovascular diseases, CNS disorders, respiratory disorders, metabolic disorders, and others)
  • [B] steps in patient recruitment process (pre-screening and screening)
  • [C] phases of development (phase I, phase II, phase III and phase IV)
  • [D] different global regions (North America, Europe, Asia-Pacific and rest of the world)

In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios portraying the conservative, base and optimistic tracks of the industry's evolution.

Market Insights

Clinical trials represent an arduous step in the drug development process and are crucial to understanding the safety and efficacy profiles of novel therapeutic interventions. As these trials are prone to delays, and can even fail altogether, they impose immense financial pressure on sponsors.

Amongst several known challenges, patient recruitment is considered to be one of the rate-limiting steps when it comes to getting drugs to the market. It is estimated that 80% of clinical trials do not meet their designated patient enrolment deadlines. In fact, around 37% of research sites fail to meet their subject accrual goals, while more than 10% don't even enroll a single patient.

In addition, retaining patients is also a matter of concern, considering that the approximate dropout rate across clinical studies is around 30%. Delays in product launch, due to inability of the sponsors to recruit/retain patients, are highly common and are estimated to result in an average loss of USD 8 million per day in opportunity costs, for a blockbuster drug.

The above-mentioned challenges have led several players in the pharmaceutical industry to outsource their patient recruitment-related needs to capable, specialty service providers. Employing contract service providers has been shown to expedite the patient recruitment process. Such service providers employ a variety of outreach methods, such as social media, mobile technologies, electronic health records (EHRs) and real-world evidence (RWE), and, over time, have attained a vital role in the successful conduct of clinical research.

Although some big pharma players carry out patient recruitment in-house, the growing complexity of clinical trials and demand for niche patient populations for studies evaluating orphan drugs / personalized medicines is likely to prompt more developer companies to outsource various aspects of their clinical research-related operations in the foreseen future.

In fact, the market has recently witnessed the establishment of several partnerships, which include agreements between study sponsors and patient recruitment firms (outsourcing deals) and partnerships between stakeholders aimed to combine their respective services portfolios related to patient recruitment and retention (service alliances). This niche services industry has also witnessed some consolidation as multiple smaller players have been acquired by more established entities, in an effort to expand geographical reach.

Key Topics Covered

1. Preface
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2. Executive Summary

3. Patient Recruitment And Retention In Clinical Trials
3.1. Chapter Overview
3.2. Clinical Trials
3.2.1. Clinical Trial Phases
3.3. Patient Recruitment
3.3.1. The Patient Recruitment Process
3.3.2. Challenges Associated with Patient Recruitment
3.3.3. Strategies to Improve Patient Recruitment
3.3.4. Ethical Considerations
3.4. Outsourcing of Patient Recruitment
3.4.1. Patient Recruitment Services
3.5. Patient Retention
3.5.1. Patient Retention Services

4. Patient Outreach Methods
4.1. Chapter Overview
4.2. Patient Outreach Methods
4.2.1. Traditional Media Physician Referrals Television Radio Print Media (Newspaper, Flyers, Brochures and Posters) Direct Mail Campaigns Cold Call / Call Center Advantages and Limitations of Traditional Media
4.2.2. Emerging / Novel Methods Social Media Social Media Platforms Used in Patient Recruitment Geo-Social Media Social Networking Websites Advantages and Limitations of Social Media Mobile / Software Applications Patient Networks Patient Advocacy Groups Electronic Medical Records (EMRs) / Electronic Health Records (EHRs) and Other Health Data Promotion of Trials in Indication Specific Events for Patients
4.2.3. Best Practices / Recommendations for Patient Outreach

5. Competitive Market Landscape Of Patient Recruitment And Retention Service Providers
5.1. Chapter Overview
5.2. Patient Recruitment and Retention Service Providers: Overall Market Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Geography
5.2.4. Analysis by Patient Recruitment and Retention Services Offered
5.2.5. Analysis by Patient Outreach Methods
5.2.6. Analysis by Patient Recruitment Associated Services
5.2.7. Analysis by Patient Retention Methods
5.2.8. Analysis by Geographical Reach
5.2.9. Analysis by Therapeutic Expertise
5.2.10. Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval / Certification / Compliance Status

6. Company Competitiveness Analysis
6.1. Chapter Overview
6.2. Methodology
6.3. Assumptions and Key Parameters
6.4. Patient Recruitment and Retention Service Providers: Company Competitiveness Analysis
6.4.1. Small-Sized Companies
6.4.2. Mid-Sized Companies
6.4.3. Large Companies

7. Company Profiles
7.1. Chapter Overview
7.2. Patient Recruitment Service Providers in North America
7.2.1. Acurian
7.2.2. BBK Worldwide
7.2.3. Bright Pharmaceuticals Services
7.2.4. ClinEdge
7.2.5. CSSi
7.2.6. CTM
7.2.7. Integrated Clinical Trial Services (ICTS)
7.2.8. MMG
7.2.9. Topstone Research
7.2.10. WCCT Global
7.3. Patient Recruitment Service Providers in Europe
7.3.1. Antidote
7.3.2. Fidelis Research
7.3.3. Ignite Data
7.3.4. Polaris BioPharma Consulting
7.3.5. Tudor Reilly Health
7.4. Patient Recruitment Services Providers in Asia Pacific
7.4.1. CROe
7.4.2. Jsure Healthmedia
7.4.3. TrialWire
7.4.4. Pacific Groove

8. Partnerships And Collaborations
8.1. Chapter Overview
8.2. Partnership Models
8.3. Patient Recruitment and Retention Services: List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnerships
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Purpose of Agreement
8.3.4. Analysis by Therapeutic Area
8.3.5. Most Active Players: Analysis by Number of Partnerships
8.3.6. Geographical Analysis

9. Recent Trends In Patient Recruitment And Retention
9.1. Chapter Overview
9.1.1. Social Media-based Campaigning to Accelerate Patient Recruitment in Clinical Trials
9.1.2. Adoption of Mobile Technologies for Patient Recruitment and Retention
9.1.3. Use of EHR Data to Improve Patient Recruitment Rates
9.1.4. Other Real World Data Sources to Help Overcome Patient Recruitment-Related Challenges
9.1.5. Growing Focus on Conducting Clinical Research in Emerging Markets

10. Future Growth Opportunities
10.1. Chapter Overview
10.1.1. Anticipated Increase in the Number of Global Clinical Trials
10.1.2. Growing Demand for Orphan Drugs and Personalized Medicine
10.1.3. Increased Offshoring of Clinical Development Operations to Emerging Regions
10.1.4. Availability of Service Providers Offering One-Stop-Solutions
10.1.5. Stringent Regulations and Complex Study Protocols Expected to Promote Outsourcing

11. Market Sizing And Opportunity Analysis
11.1. Chapter Overview
11.2. Forecast Methodology and Key Assumptions
11.3. Overall Patient Recruitment Services Market, 2019-2030
11.4. Patient Recruitment Services Market: Distribution by Therapeutic Area, 2019-2030
11.5. Patient Recruitment Services Market: Distribution by Steps in Patient Recruitment Process, 2019-2030
11.6. Patient Recruitment Services Market: Distribution by Phase of Development, 2019-2030
11.7. Patient Recruitment Services Market: Distribution by Geography, 2019-2030
11.7.1. Patient Recruitment Services Market: Market Attractiveness Analysis by Country, 2019-2030
11.7.2. Patient Recruitment Services Market in North America, 2019-2030
11.7.3. Patient Recruitment Services Market in EU5, 2019-2030
11.7.4. Patient Recruitment Services Market in Asia Pacific, 2019-2030
11.7.5. Patient Recruitment Services Market in Rest of the World, 2019-2030

12. Conclusion
12.1. Evolving Requirements Related to Patient Enrolment have Imposed a Significant Burden on Drug Developers, Causing Many to Outsource their Recruitment and Retention-related Processes
12.2. Several CROs Offer Patient Recruitment and Retention Services across the Globe; North America and Europe have Emerged as Key Hubs
12.3. Currently, a Variety of Outreach Methods are being used to Enroll Patient from Across Different Geographies and Therapeutic Areas
12.4. Innovation, Use of Real World Evidence and the Establishment of Strategic Alliances between Stakeholders are Anticipated to Act as Key Market Enablers
12.5. Driven by the Increasing Demand for Niche and Highly Specific Patient Populations in Clinical Trials, the Patient Recruitment Services Market is Anticipated to Witness Significant Growth in the Coming Decade

13. Interview Transcripts
13.1. Chapter Overview
13.2. Link2Trials
13.3. nRollmed
13.4. Seeker Health

Companies Mentioned

  1. Abnex
  2. Access Clinical Research
  3. Accurate Clinical Research
  4. Acurian
  6. Advanced Clinical
  7. Affordable Clinical Trials Outsourcing
  8. Akcelis
  9. Alleco Trials
  10. Alliance for Clinical Research Excellence and Safety
  11. Allscripts
  12. American Liver Foundation
  13. American Society of Clinical Oncology
  14. Amgen
  15. Antidote
  16. ApotheCom
  17. Apparelyzed
  18. Apptomics
  19. AQLANE Medical
  20. Arden and Schmidt
  21. AstraZeneca
  22. ATLAS Medical Services
  23. AutoCruitment
  24. AXELLE Group
  25. Axiom Marketing
  26. BBK Worldwide
  27. BDD
  28. BIAPharm
  29. Bio-Optronics
  30. Bioclinica
  31. BioScript
  32. Bladder & Bowel Community
  33. Blueprint Clinical
  34. BlueTheory Clinical Trials
  35. BMC Group
  36. Box
  37. Bridge Clinical Research
  38. Bright Pharmaceutical Services
  39. Buzzreach
  40. C&C Clinical Laboratory Consulting
  41. Canadian Institute for Medical Advancement
  42. Capsule Communications
  43. CaringKind
  44. CarthagoPharma
  45. Center Point Clinical Services
  46. Centricity Health
  47. Chandler Chicco Agency
  48. Chase Medical Research
  49. Cinven
  50. Circuit Clinical
  51. Clariness
  52. Clear Clinica
  53. Clinart MENA
  54. ClinEdge
  55. Clinerion
  56. Clinical Ambassador
  57. Clinical List America
  58. Clinical Trial
  59. Clinical Trial Connect
  60. Clinical Trial Marketing Communications
  61. Clinical Trial Networking
  62. Clinical Trials Center
  63. Clinical Trials Group
  64. ClinicalConnection
  65. Clinically Media
  66. ClinIntel
  67. CliniSpan Health
  68. Clinspire Research
  69. Clintec
  70. Clintract
  71. Clinverse
  72. CMX Research
  73. Compass Research
  74. Continuum Clinical
  75. CPS Research
  76. CROee
  77. CSSi
  78. CTM
  79. Cyclone
  80. Cytespace
  81. DAC Patient Recruitment Services
  82. DAVA Oncology
  83. DrFirst
  84. Eastern Medical
  85. Effectus CTR
  86. EGeen
  87. Elligo Health Research
  88. EmergingMed
  89. eNre
  90. ePatientFinder
  91. eStudySite
  92. Euclid SR Partners
  93. European Organization for Research and Treatment of Cancer
  95. FDAMap
  96. Fidelis Research
  97. Flatiron Health
  98. Foundation for the National Institutes of Health
  99. Foundation Medicine
  100. Friends of Cancer Research
  101. Gaea Clinical
  102. Galen Patient Recruitment
  103. GCP Clinical Studies
  104. Genentech
  105. Gitzo Pharmaceuticals
  106. Global Clinical Trials
  107. Global Perspectives
  108. GuideStar Research
  109. Heron Therapeutics
  110. Ignite Data
  111. IMS Health
  112. Incontinence UK
  113. Innovative Trials
  114. INSPIRE
  115. Institute of Clinical Research India
  116. Integrated Clinical Trial Services
  117. IQVIA
  118. IRM
  119. J Trotter Research & Consulting
  120. JLL Partners
  121. JP Morgan Partners
  122. KCR
  123. Klick Health
  124. Langland
  125. LeadSlinger
  126. Linical Accelovance
  127. Link2Trials
  128. Live Doctors
  129. LongTaal
  130. Lyft
  131. Lymphoma Action
  132. Medical Research South
  133. MediciGroup
  134. Melanoma Research Alliance
  135. Merck Capital Ventures
  136. Miami Research Associates
  137. MMG
  138. Mondosano
  139. Mundipharma Research
  140. National Cancer Institute
  141. Northumbria Healthcare NHS Foundation Trust
  142. nRollmed
  143. O4 Research
  144. One Research
  145. orphan reach
  146. Orphanos
  147. Osaka International Cancer Institute
  148. Pacific Grove
  149. Parallel 6
  150. PAREXEL
  151. Patient Enrollment Advisors
  152. Patient RM
  153. PatientEvolution
  154. Patients Direct
  155. PatientWise
  156. Patiro
  157. Pepgra
  158. Pfizer
  159. Pharm-Olam
  160. PharmaCentra
  161. Pharmaceutical Product Development
  162. phaware global association
  163. Physicians Plasma Alliance
  164. Polaris Biopharma Consulting
  165. PPH plus
  166. Practice Fusion
  167. Praxis Communications
  168. PRC Clinical
  169. Profil
  170. ProQuest Investments
  171. Publicis Healthcare Communications Group
  172. PWNHealth
  173. QPS
  174. Radiant Research
  175. RealTime Software Solutions
  176. RemediumOne
  177. Remedy Health Media
  178. Rep Network
  179. RESolutions
  180. Roche
  181. S4 Research
  182. Seeker Health
  183. Sinque Labs
  184. SitePartner
  185. SMO Clinical Research
  186. SMO ClinPlus
  187. Society for Clinical Research Sites
  188. Spectrum Clinical Research
  189. Spinal Cord Injury Network
  190. Splash Clinical
  191. SubjectWell
  192. SWOG Cancer Research
  193. Syneos Health
  194. Synexus
  195. TFS
  196. The Academic Network
  197. The Patient Experience Project
  198. The Patient Recruiting Agency
  199. The Patient Recruitment Consultancy
  200. ThreeWire
  201. Topstone Research
  202. Total Clinical Trial Management
  203. Trial Connections
  204. Trialfacts
  205. TrialJoin
  206. TrialSpark
  207. TrialWire
  208. Tudor Reilly Health
  209. United BioSource
  210. University of Exeter
  211. University of Glasgow
  212. University of Strathclyde
  213. Veristat
  214. Viomedo
  215. VisibilityRx
  216. Vizae Clinical Trial Management
  217. WCCT Global
  218. WIRB-Copernicus Group
  219. Worldwide Clinical Trials
  220. X Factor Advertising

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:

SOURCE Research and Markets